Osteochondroma of Antero Medial Maxillary Wall - A Rare Case Report.

A 17 year female came with complaints of swelling over left lateral wall of nose and left nasal block was found to have osteochondroma of maxilla on CT PNS, resected by sub labial approach with postoperative histopathological confirmation. Thus describing a rare case of osteochondroma of maxilla treated without any cosmetic and functional impairment.

Evaluation of the Effects of Dyslipidemia on Hearing in Patients with Type 2 Diabetes Mellitus.

Modernization has led to change in life style and physical inactivity which are playing a major role in increasing the number of people with diabetes and dyslipidaemia, Different types of hearing loss in diabetic patients have been reported which shows progressive, gradual, bilateral sensorineural loss. The primary aim of the present study is to evaluate the effects of dyslipidemia on hearing in patients with type 2 diabetes mellitus. A comparative study was conducted where patients were divided into 4 groups-Type II diabetes mellitus with dyslipidemia,Type II diabetes mellitus with normal lipid profile, Only Dyslipidemia,Normal subjects. A total of 128 participants were enrolled in the study. The Diabetes patient was determined by the FBS, PPBS and Hba1c levels. Dyslipidemia determined by LDL,HDL,VLDL.Patients with Type 2 diabetes mellitus and dyslipidaemia was evaluated for the presence of hearing loss with the help of PTA. Prevalence of hearing loss among patients with Diabetes and Dyslipidaemia was 65.7%, 40.6% in Type II DM with normal lipid profile patients, 18.75% in patients with dyslipidaemia. Statistically significant association of hearing loss was noted in patients with diabetes mellitus and dyslipidaemia. Although hearing loss is multifactorial, control of the risk factors like dyslipidaemia in diabetes mellitus definitely halt the process of auditory damage. As observed from this study, poor glycaemic control, associated other co-morbidities were contributing factors for hearing loss. Healthy life style with early recognition of these diseases helps in preventing further damage.

Cholesteatoma Classification: Review of Literature and Proposed Indian Classification System-TAMPFIC.

Classification systems provides a tool for segregating cases based on their similarities. It can be used by healthcare professionals for representation, comparison, communication, discussion and for standardizing treatment protocols across the geographical boundaries. Cholesteatoma is prevalent in developed as well as developing nations posing a great burden on economic and health sector. Even though systems for classification of cholesteatoma are already being used in some places, however none of them is yet universally accepted due to their complex nature. After a thorough review of the most popular systems, we attempt to propose an Indian classification system for cholesteatoma "TAMPFIC". The system is based on clinical representations and will allow us to standardize the reporting of the disease and its extension along with all possible complications in a simple and unique way and will also help in reporting surgical outcomes for the same. Reporting of surgical outcomes will not only help in comparison but will also help in standardizing treatment protocols for similar kind of cases in future. It will require multi centric approach for validating our system to reach a common consensus for defining treatment protocols. We hope this system acquires universal acceptance and presents itself as a single new tool for classification of cholesteatoma with international consensus in near future.

New Visionary in Upper Airway Surgeries-THRIVE, a Tubeless Ventilation.

THRIVE stands for Transnasal Humidified Rapid Insufflation Ventilatory Exchange. Usage of THRIVE technique is common in emergency settings and of late its usage in upper airway surgeries is gaining popularity. (1) To determine the operative time, total anaesthesia time, safety and efficacy of THRIVE in patients undergoing upper airway surgeries for varied pathologies. (2) To assess the surgeon's satisfaction and patients post-operative comfort. An observational study was from May 2019 to Oct 2020. Study was conducted through a detailed proforma which consists of patient demographic details, physical status, co-morbidities and various domains to assess the safety and efficacy of THRIVE. A total of 32 patients were divided into four groups depending on the type of surgery. We had 18 patients in microlaryngeal excision, six in direct laryngoscopy and biopsy, four in tracheostomy and four in balloon dilatation for subglottic stenosis groups. The mean operation time was 16 ± 2 min in the first three groups and 29 ± 0.8 in the fourth group. All the patients underwent successful surgeries without any episodes of desaturation, without complications and with good surgical satisfaction. THRIVE with appropriate safety precautions can be tried in patients undergoing various upper airway surgeries of short duration. All the patients in our study maintained stable vital parameters throughout the surgery. Initial results with the use of THRIVE as per our study and other studies are definitely encouraging to use THRIVE in upper airway surgeries with varied pathologies.

Hearing Loss-a Camouflaged Manifestation of COVID 19 Infection.

The symptomatology of novel Severe Acute Respiratory Syndrome Corona virus type 2 infection runs the entire gamut of mild to moderate and serious illness among the affected individuals. As listed in recent literature, respiratory, cardiovascular, gastrointestinal, olfactory and gustatory systems are commonly involved. With the growing knowledge about the disease, varied manifestations have been identified and lately, otorhinolaryngology dysfunctions in COVID 19 have been described. Hearing loss in COVID era is one of the emerging areas of concern and calls for further research in the field for the better understanding and treatment of this entity. This study was designed to assess the audiological profile among 100 mild to moderately affected COVID-19 individuals, so as to make a contribution to the emerging literature on otologic manifestations in COVID 19. In our case series, high frequency hearing loss and referred OAE was noted among significant number of COVID 19 positive patients. This was even observed in patients without any otologic symptoms. Hence, early identification and intervention if required helps to give a better quality of life to the patient.